MCCORMICK FRANK (CIK 1257809) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-24). Recent activity: Buy BBIO (3,990 shares), Sell BBIO (111,755 shares), Sell BBIO (31,116 shares), Sell BBIO (3,497 shares), Sell BBIO (8,598 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 3,990 | $0 |
| 2025-10-31 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 111,755 | $7.3M |
| 2025-10-31 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 31,116 | $2.1M |
| 2025-10-31 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 3,497 | $236,117 |
| 2025-10-31 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 8,598 | $588,963 |
| 2025-10-31 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 43,393 | $3.0M |
| 2025-10-29 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 1,641 | $106,665 |
| 2025-09-08 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 74,000 | $882,080 |
| 2025-09-08 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 74,000 | $3.9M |
| 2025-06-26 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 100,000 | $4.4M |
| 2025-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 6,589 | $0 |
| 2025-05-09 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 33,000 | $0 |
| 2025-05-09 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 3,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-24